miR-9 is a tumor suppressor in pediatric AML with t(8;21)

MicroRNAs (miRNAs) play a pivotal role in the regulation of hematopoiesis and development of leukemia. Great interest emerged in modulating miRNA expression for therapeutic purposes. In order to identify miRNAs, which specifically suppress leukemic growth of acute myeloid leukemia (AML) with t(8;21), inv(16) or mixed lineage leukemia (MLL) rearrangement by inducing differentiation, we conducted a miRNA expression profiling in a cohort of 90 cytogenetically characterized, de novo pediatric AML cases. Four miRNAs, specifically downregulated in MLL-rearranged, t(8;21) or inv(16) AMLs, were characterized by their tumor-suppressive properties in cell lines representing those respective cytogenetic groups. Among those, forced expression of miR-9 reduced leukemic growth and induced monocytic differentiation of t(8;21) AML cell lines in vitro and in vivo. The tumor-suppressive functions of miR-9 were specifically restricted to AML cell lines and primary leukemic blasts with t(8;21). On the other hand, these functions were not evident in AML blasts from patients with MLL rearrangements. We showed that miR-9 exerts its effects through the cooperation with let-7 to repress the oncogenic LIN28B/HMGA2 axis. Thus, miR-9 is a tumor suppressor-miR which acts in a stringent cell context-dependent manner.

[1]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[2]  B. Torbett,et al.  Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells , 2012, British journal of haematology.

[3]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[4]  J. Rowley,et al.  miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia–rearranged leukemia , 2013, Proceedings of the National Academy of Sciences.

[5]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[6]  M. Sieweke,et al.  MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated Functional Macrophages , 2009, Science.

[7]  G. Daley,et al.  Selective Blockade of MicroRNA Processing by Lin28 , 2008, Science.

[8]  Charles Lee,et al.  The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. , 2006, Blood.

[9]  R. Mantovani,et al.  Transcriptional Activation of the Cyclin A Gene by the Architectural Transcription Factor HMGA2 , 2003, Molecular and Cellular Biology.

[10]  M Suzuki,et al.  Explorer Induction of microRNAs , mir-155 , mir-222 , mir-424 and mir-503 , promotes monocytic differentiation through combinatorial regulation , 2010 .

[11]  B. Ebert,et al.  miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation , 2013, Leukemia.

[12]  J. M. Thomson,et al.  Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. , 2008, RNA.

[13]  D. Reinhardt,et al.  Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children , 2001, Annals of Hematology.

[14]  S. Orkin,et al.  miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia. , 2010, Genes & development.

[15]  A. Schambach,et al.  Mechanisms controlling titer and expression of bidirectional lentiviral and gammaretroviral vectors , 2010, Gene Therapy.

[16]  C. Joo,et al.  Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. , 2008, Molecular cell.

[17]  Xiaowei Wang.  miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.

[18]  R. Pieters,et al.  Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia , 2012, Pediatric blood & cancer.

[19]  M. Odero,et al.  Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies , 2005, Leukemia.

[20]  Bob Löwenberg,et al.  MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.

[21]  F. Slack,et al.  RAS Is Regulated by the let-7 MicroRNA Family , 2005, Cell.

[22]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[23]  L. Smirnova,et al.  A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment , 2008, Nature Cell Biology.

[24]  R. Pieters,et al.  Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia , 2011, Haematologica.

[25]  M. Caligiuri,et al.  Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  L. Bullinger,et al.  The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML , 2013, Leukemia.

[27]  S. Muljo,et al.  Lin28b Reprograms Adult Bone Marrow Hematopoietic Progenitors to Mediate Fetal-Like Lymphopoiesis , 2012, Science.

[28]  J. Rowley,et al.  Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. , 2009, Blood.

[29]  D. Bartel,et al.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.

[30]  D. Reinhardt,et al.  Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy , 2013, Leukemia.

[31]  J. Rowley,et al.  Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis , 2013, Proceedings of the National Academy of Sciences.

[32]  C. Croce,et al.  Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas , 2002, Oncogene.

[33]  H. Lodish,et al.  MicroRNAs in erythroid and megakaryocytic differentiation and megakaryocyte–erythroid progenitor lineage commitment , 2012, Leukemia.

[34]  David P. Bartel,et al.  Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .

[35]  R. Pieters,et al.  Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. , 1994, British Journal of Cancer.

[36]  F. Slack,et al.  let-7 microRNAs in development, stem cells and cancer. , 2008, Trends in molecular medicine.

[37]  S. Emmrich,et al.  miRNAs can increase the efficiency of ex vivo platelet generation , 2012, Annals of Hematology.

[38]  M. Caligiuri,et al.  Increased anti-leukemic activity of decitabine via AR-42-induced upregulation of miR-29b: a novel epigenetic-targeting approach in acute myeloid leukemia , 2013, Leukemia.

[39]  R. Ashmun,et al.  c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. , 1999, Blood.

[40]  Yuka Nakamura,et al.  Aberrant expression of MIR9 indicates poor prognosis in acute myeloid leukaemia , 2012, British journal of haematology.

[41]  Dimitrios Iliopoulos,et al.  Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms , 2011, Cell.

[42]  Y. Pekarsky,et al.  Reprogramming of miRNA networks in cancer and leukemia. , 2010, Genome research.

[43]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[44]  Herman Van den Berghe,et al.  Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours , 1995, Nature Genetics.

[45]  M. Caligiuri,et al.  Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.

[46]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[47]  D. V. Vactor,et al.  NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript NIH Public Access Author Manuscript Nat Methods. Author manuscript; available in PMC 2011 September 30. , 2009 .

[48]  Zhongwei Cao,et al.  miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis , 2011, Journal of Cancer Research and Clinical Oncology.

[49]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[50]  Anindya Dutta,et al.  The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. , 2007, Genes & development.

[51]  D. Johnston,et al.  Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. , 2012, Blood.

[52]  Allen D. Delaney,et al.  Comprehensive microRNA expression profiling of the hematopoietic hierarchy , 2010, Proceedings of the National Academy of Sciences.

[53]  S. Orkin,et al.  Developmental stage-specific interplay of GATA1 and IGF signaling in fetal megakaryopoiesis and leukemogenesis. , 2010, Genes & development.